(Q34528756)

2 August 2017

Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus (English)

1 reference

2 August 2017

0 references

0 references

0 references

Luigi Brunetti

1

1 reference

2 August 2017

Lucia Recinella

2

1 reference

2 August 2017

Giustino Orlando

3

1 reference

2 August 2017

Barbara Michelotto

4

1 reference

2 August 2017

Chiara Di Nisio

5

1 reference

2 August 2017

Michele Vacca

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

European Journal of Pharmacology

2 August 2017

1 reference

2 August 2017

454

1 reference

2 August 2017

2-3

1 reference

2 August 2017

189-192

1 reference

Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin.

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Permeability of the blood-brain barrier to amylin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Leptin inhibits norepinephrine and dopamine release from rat hypothalamic neuronal endings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Cocaine- and amphetamine-regulated transcript peptide-(55-102) and thyrotropin releasing hormone inhibit hypothalamic dopamine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Anorexia following the systemic injection of amylin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Dexfenfluramine. An updated review of its therapeutic use in the management of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Distribution of amylin-immunoreactive neurons in the monkey hypothalamus and their relationships with the histaminergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Evidence that neuropeptide Y and dopamine in the perifornical hypothalamus interact antagonistically in the control of food intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Interacting appetite-regulating pathways in the hypothalamic regulation of body weight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Hypothalamic serotonin in control of eating behavior, meal size, and body weight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Amylin: history and overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Dopamine D(2) receptors mediate amylin's acute satiety effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

A role for ghrelin in the central regulation of feeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Effects of cocaine- and amphetamine-regulated transcript peptide, leptin and orexins on hypothalamic serotonin release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Neurobehavioural mechanisms of reward and motivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Amylin: a novel action in the brain to reduce body weight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Neurochemical mechanism of action of anorectic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Dopamine is required for hyperphagia in Lep(ob/ob) mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Ghrelin induces adiposity in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Modulation of feeding by hypothalamic paraventricular nucleus alpha 1- and alpha 2-adrenergic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

Ghrelin causes hyperphagia and obesity in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

LHA dopaminergic activity in obese and lean Zucker rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902552-9

10.1016/S0014-2999(02)02552-9

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference